A+ | A | A- | Skip to main content |

800 years stamp

Sensex

Nifty

USDINR

GBPINR

EURINR

BSE
NSE

Thursday, 07 May 2026 03:59 PM	Asian-Paints2529.45	Hind-Unilever2272.80	ITC307.65	Trent4293.10	Larsen-and-Toubro4022.50	M-and-M3367.35	Reliance-Industries1435.70	Tata-Steel217.05	Titan-Company4308.50	SBI1091.80	Bharat-Electron439.70	Kotak-Mah-Bank380.65	Infosys1162.50	Bajaj-Finance972.45	Sun-PharmaInds1831.30	HDFC-Bank795.85	TCS2401.75	ICICI-Bank1278.85	Power-Grid-Corpn313.60	Maruti-Suzuki13766.95	Axis-Bank1292.35	HCL-Technologies1183.45	NTPC400.45	Bharti-Airtel1826.45	Tech-Mahindra1448.00	Adani-Ports1732.85	UltraTech-Cem12144.45	Bajaj-Finserv1824.25	Interglobe-Aviat4507.75	Eternal257.35
15 mins delay SENSEX 77,844.52 [-114.00]	10.60 0.42%	-45.20 -1.95%	-2.95 -0.95%	0.50 0.01%	14.15 0.35%	67.35 2.04%	-2.15 -0.15%	1.50 0.70%	-49.75 -1.14%	-3.80 -0.35%	1.55 0.35%	4.45 1.18%	-4.80 -0.41%	-8.20 -0.84%	-19.10 -1.03%	-0.75 -0.09%	-33.60 -1.38%	-0.60 -0.05%	-2.15 -0.68%	46.40 0.34%	-3.75 -0.29%	-5.45 -0.46%	5.75 1.46%	-6.95 -0.38%	-18.85 -1.29%	-15.20 -0.87%	50.95 0.42%	-12.00 -0.65%	-11.80 -0.26%	1.45 0.57%

Hot Pursuit

Scrips, which has significant changes during the market hours.

Indoco Remedies gains after reporting turnaround Q4 performance

07-May-26 15:29Hrs IST

Revenue from operations stood at Rs 429.06 crore in the fourth quarter of FY26, up 25.79% as against Rs 341.07 crore posted in Q4 FY25.

The company reported a profit before tax of Rs 27.62 crore in Q4 FY26, compared with a pre-tax loss of Rs 30.90 crore in Q4 FY25. It also recorded exceptional items of Rs 3.68 crore during the quarter.

On a consolidated basis, the company reported consolidated net loss of Rs 23.68 crore in Q4 FY26 as against net loss of Rs 41.34 crore in Q4 FY25. Revenue from operations surged 18.75% to Rs 455.9 crore in Q4 FY26 as against Rs 383.89 crore in Q4 FY25.

EBITDA for the quarter stood at Rs 63 crore, compared with Rs 3.5 crore in the corresponding quarter of the previous year. EBITDA margin for the quarter stood at 14.7% as against 1.0% in the same quarter last year.

For the year, revenue stood at Rs 1,633.5 crore as against Rs 1,494.8 crore in the same period last year. EBITDA stood at Rs 157.2 crore, compared with Rs 128 crore in the corresponding period last year, while EBITDA margin improved to 9.6% from 8.6%.

Aditi Panandikar, Managing Director, Indoco Remedies, said, 'Revenue growth for the quarter and year was mainly driven by a good performance in the International Formulations Business, supported by a steady growth in the API & Services Businesses.'

The board of directors recommended a dividend of Rs 0.20 per equity share of face value Rs 2 each for the financial year 2025'2026.

Indoco is a fully integrated, research-oriented pharmaceutical company with a strong global presence. The company's turnover is US$ 175 million with human capital of over 6000 employees, including over 300 skilled scientists and field staff who are the strength of the organization.

Powered by Capital Market - Live News

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

"Contents which are exclusively for Non-Broking Products/Services, "Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."

A Muthoot M George Enterprise